Search
NVS antibody
go.drugbank.com/drugs/DB05312ExperimentalThis drug has been developed using Medarex's UltiMAb Human Antibody Development System to treat autoimmune diseases.
Tamibarotene
go.drugbank.com/drugs/DB04942InvestigationalTamibarotene is currently approved in Japan for treatment of recurrent APL, and is undergoing clinical trials in the United States.
Budigalimab
go.drugbank.com/drugs/DB16668InvestigationalWith IV Modified FOLFIRINOX (Mffx) With or Without IV Budigalimab Compared to Mffx in Adult Participants With Untreated Pancreatic Cancer Metastasis). … Budigalimab is under investigation in clinical trial NCT04807972 (Study to Evaluate Adverse Events and Change in Disease Activity When Intravenous (IV) Infusion of ABBV-927 Is Administered in Combination
Pritelivir
go.drugbank.com/drugs/DB11844InvestigationalPritelivir has been used in trials studying the prevention of HSV-2 and Genital Herpes.
gp209-2M antigen
go.drugbank.com/drugs/DB17462InvestigationalThe gp209-2M antigen is derived from gp209, and has potential immunomodulatory and antineoplastic activities.
RP-L301
go.drugbank.com/drugs/DB17661InvestigationalRP-L301 is a lentiviral vector containing the human liver and erythroid pyruvate kinase gene.
AAV-RPE65
go.drugbank.com/drugs/DB18343ExperimentalAAV-RPE65 is an adenovirus associated viral vector serotype 5 containing the human RPE65 gene
Heparan-N-sulfatase (human, recombinant)
go.drugbank.com/drugs/DB18483InvestigationalRecombinant human heparan-N-sulfatase (rhHNS) is under investigation for the treatment mucopolysaccharidosis type IIIA.
Glial growth factor 2
go.drugbank.com/drugs/DB12841InvestigationalGlial growth factor 2 has been used in trials studying the treatment of Heart Failure.
BMS-908662
go.drugbank.com/drugs/DB12854InvestigationalBMS-908662 has been used in trials studying the treatment of Melanoma and Colorectal Cancer.